BioGenerator

Summary

In 2003 was created BioGenerator, which is appeared as VC. The venture was found in North America in United States. The main department of described VC is located in the St Louis.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline MediBeacon, Benson Hill Biosystems, S4 Among the most successful fund investment fields, there are Pharmaceutical, Therapeutics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.

The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. Comparing to the other companies, this BioGenerator performs on 27 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 4 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2017.

The overall number of key employees were 5.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the BioGenerator, startups are often financed by St. Louis Arch Angels, Serra Ventures, Missouri Technology Corporation. The meaningful sponsors for the fund in investment in the same round are iSELECT FUND, The Yield Lab, Helix Fund. In the next rounds fund is usually obtained by St. Louis Arch Angels, Billiken Angels Network, Argonautic Ventures.